Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Use of acetazolamide to decrease cerebrospinal fluid production in chronically ventilated patients with

E Carrion1, J H Hertzog, M D Medlock

  • 1Department of Pediatrics, Division of Pediatric Critical Care and Pulmonary Medicine, Georgetown University Medical Center, Washington, DC, USA.

Archives of Disease in Childhood
|December 22, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Report of Root Rot Caused by Fusarium proliferatum on Blueberry in Argentina.

Plant disease·2019
Same author

Hemorrhage/contrast staining areas after mechanical intra-arterial thrombectomy in acute ischemic stroke: imaging findings and clinical significance.

AJNR. American journal of neuroradiology·2012
Same author

Inhaled nitric oxide in neurogenic cardiopulmonary dysfunction: implications for organ donation.

Transplantation proceedings·2004
Same author

The use of a mobile computed tomography scanner in the pediatric intensive care unit to evaluate airway stenting and lung volumes with varying levels of positive end-expiratory pressure.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2003
Same author

T-cell responses in burn infection.

Critical care medicine·2002
Same author

Lung volume measurement during high-frequency ventilation: a new role for an old technique?

Critical care medicine·2002
Same journal

Protecting adolescent confidentiality in the digital age: a global call for adolescent-informed electronic health records.

Archives of disease in childhood·2026
Same journal

Diagnostic accuracy study assessing the ability of paediatric asthma scores to predict admission following initial emergency department bronchodilator therapy: a Clinical Asthma Scoring systems in Paediatric Emergency (CASPER) study.

Archives of disease in childhood·2026
Same journal

Artificial intelligence for child health: current capabilities and the next frontier.

Archives of disease in childhood·2026
Same journal

Troubled origins and lasting impact of the first insulin injection.

Archives of disease in childhood·2026
Same journal

Paediatric readiness assessment tools in emergency care: a scoping review.

Archives of disease in childhood·2026
Same journal

Building a paediatric workforce to deliver the NHS prevention agenda: time for paediatric public health medicine?

Archives of disease in childhood·2026
See all related articles

Acetazolamide (ACTZ) reduced cerebrospinal fluid (CSF) production in pediatric hydrocephalus patients, improving ventriculopleural shunt tolerance. This carbonic anhydrase inhibitor treatment requires monitoring for metabolic disturbances.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pediatric Medicine

Background:

  • Hydrocephalus management often involves shunts, but complications like shunt failure are common.
  • Carbonic anhydrase inhibitors, such as Acetazolamide (ACTZ), are known to reduce cerebrospinal fluid (CSF) production in animal models.
  • Pediatric hydrocephalus presents unique challenges, especially in patients requiring mechanical ventilation.

Observation:

  • Two pediatric patients with hydrocephalus and recurrent shunt failures were treated with Acetazolamide (ACTZ) prior to ventriculopleural shunt placement.
  • Externalized ventriculostomy drain (EVD) CSF output was monitored during escalating doses of ACTZ.
  • The study observed the effects of ACTZ on CSF volume and shunt tolerance in these children.

Findings:

Related Experiment Videos

  • Acetazolamide (ACTZ) treatment led to a significant decrease in EVD CSF output, with reductions of 48% and 39% at maximum doses.
  • This is the first reported instance of altered CSF volume in children following extended Acetazolamide (ACTZ) therapy.
  • The study demonstrated a dose-dependent effect of ACTZ on CSF production in pediatric patients.

    • Implications:

    • Acetazolamide (ACTZ) may enhance the tolerance of ventriculopleural shunts in mechanically ventilated pediatric patients with hydrocephalus.
    • This therapeutic approach could potentially minimize respiratory compromise associated with hydrocephalus management.
    • Careful monitoring and supplementation with potassium and bicarbonate are essential to manage ACTZ-induced metabolic disturbances.